Loading the session
Loading the session
Loading instrument
$2.93
−1.54%DelayedDelayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 20:27 IST · A quote does not mean the product is available to trade on your account.
In brief
Questions investors ask
Quotes run fifteen minutes behind.
Closed at $2.98 on 4 Nov 2026: 100.0% below the 52-week high of $2,520,000.00 (7 Jan 2026) and 10.0% above the low of $2.71 (3 Nov 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
1 month: −98.5% (SPY −1.0%). 3 months: −99.5% (SPY +1.2%). 1 year: −100.0% (SPY +13.6%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: SXTC, SPY · as of 4 Nov 2026
The 4 Nov 2026 close of $2.98 was 98.2% below its 50-day average ($162.12) and 100.0% below its 200-day average ($14,707.46). It has closed below the 200-day for 206 sessions, since 8 Jan 2026.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
The 14-session relative strength index closed at 21.6 on 4 Nov 2026, its 73rd session at 30 or below. By convention a reading of 30 or below is called oversold and 70 or above overbought.
Daily closes, split-adjusted; Wilder's 14-session RSI · as of 4 Nov 2026
4 Nov 2026 volume of 127.3K shares was 0.4× the average of the 30 sessions before it (319.9K), as the price rose 3.5%. SPY traded 1.5× its own average that session.
Daily volume against a 30-session baseline · as of 4 Nov 2026
Price return, split-adjusted
At the 4 Nov 2026 close
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly TCMP (Directed-oral TCMP and After-soaking TCMP), which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
October 12, 2026
−79.22%July 22, 2026
−83.35%January 9, 2026
−88.58%